The newly reorganized, streamlined NeuroAssessment Core (NAC) will have the overall goal of supporting comprehensive neuromedical, neurobehavioral and neuroimaging assessments for the characterization of HIV+ individuals and HIV- controls in HNRC-affiliated studies. The Core will comprise 3 integrated subunits: Neuromedical (NM), Neurobehavioral (NBh) and Neuroimaging (NI).
We aim to facilitate and enhance multidisciplinary research in neuroAIDS by providing a range of services, training and scientific consultation to projects such as investigator-driven R01s and R21s, international neuroAIDS studies, and a variety of intra- and extramural investigations. Historically the Core and its investigators have been leaders in the field, spurring the development of new methods and adapting to the continually evolving scientific landscape. Consistent with this, the Core will provide resources to support the Center's new themes of HIV persistence and cure, and how the human gut microbiome interacts with HIV and its treatment to affect the CNS. Specific services relevant to HIV persistence and cure include serial lumbar punctures to evaluate viral rebound following HIV reservoir interventions, and high volume CSF collection and neurocognitive (NC) testing to assess effects of such interventions on brain functioning. The gut microbiome will be characterized by collecting and processing samples of stool. Standard evaluations will continue to include a structured neuromedical history, clinical and laboratory examinations, and establishment of diagnoses of central and peripheral neurological complications of HIV. The NAC's NI Unit will provide resources, including training, consultation, and technical support, for the detection and measurement of HIV- related brain injury using a broad array of techniques, including structural, functional, and metabolite MRI and PET imaging. This work will support investigations of the cognitive consequences and neuromedical correlates of these effects; the underlying pathological mechanisms that give rise to this damage; and potential biomarkers for treatment success. The NBh Unit will perform a comprehensive assessment of all participants in the HNRC cohort that will include well-validated measures of NC functioning, psychiatric status, and everyday functioning, in accordance with the HAND diagnostic guidelines. The NBh Unit's specific Resource Objectives are to provide: 1) demographically-adjusted individual, domain, and global summary scores of NC functioning; 2) Determinations of NC change in individual participants using reliable and validated actuarial methods; 3) Self-assessment and laboratory-based measures of everyday functioning; 4) Current and lifetime history of mood and substance use diagnoses; and 5) Technical assistance, training, certification, consultation, and career development mentoring. Data generated by the NAC range from NC performance and diagnostic formulations to ART information, disease staging and viral loads (VLs), to clinical laboratory measurements, medical histories, and physical examinations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062512-17
Application #
9279257
Study Section
Special Emphasis Panel (ZMH1-ERB-M)
Project Start
Project End
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
17
Fiscal Year
2017
Total Cost
$446,743
Indirect Cost
$158,521
Name
University of California San Diego
Department
Type
Domestic Higher Education
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Babakhanyan, Ida; McKenna, Benjamin S; Casaletto, Kaitlin B et al. (2018) National Institutes of Health Toolbox Emotion Battery for English- and Spanish-speaking adults: normative data and factor-based summary scores. Patient Relat Outcome Meas 9:115-127
Moore, David J; Pasipanodya, Elizabeth C; Umlauf, Anya et al. (2018) Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial. Drug Alcohol Depend 189:154-160
Hoenigl, Martin; Moser, Carlee; Funderburg, Nicholas et al. (2018) Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression. Clin Infect Dis :
Hellmuth, Joanna; Milanini, Benedetta; Masliah, Eliezer et al. (2018) A neuropathologic diagnosis of Alzheimer's disease in an older adult with HIV-associated neurocognitive disorder. Neurocase 24:213-219
Lin, Timothy C; Dijkstra, Maartje; De Bree, Godelieve J et al. (2018) Brief Report: The Amsterdam Symptom and Risk-Based Score Predicts for Acute HIV Infection in Men Who Have Sex With Men in San Diego. J Acquir Immune Defic Syndr 79:e52-e55
MacDuffie, Katherine E; Brown, Gregory G; McKenna, Benjamin S et al. (2018) Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume. Neuroimage Clin 20:1044-1052
Sundermann, Erin E; Heaton, Robert K; Pasipanodya, Elizabeth et al. (2018) Sex differences in HIV-associated cognitive impairment: an observational cohort study. AIDS :
Chow, Felicia C; Makanjuola, Akintomiwa; Wu, Kunling et al. (2018) Physical activity is associated with lower odds of cognitive impairment in women but not men living with HIV infection. J Infect Dis :
Jumare, Jibreel; El-Kamary, Samer S; Magder, Laurence et al. (2018) Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria. J Neurovirol 24:712-719
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963

Showing the most recent 10 out of 743 publications